share_log

Orthofix Medical Analyst Ratings

Benzinga ·  Sep 12, 2023 11:58
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/12/2023 BTIG Downgrades Buy → Neutral
09/12/2023 14.45% Stifel $30 → $16 Downgrades Buy → Hold
07/19/2023 93.13% BTIG → $27 Reinstates → Buy
03/04/2022 221.89% Stifel $41 → $45 Upgrades Hold → Buy
10/20/2020 178.97% Stifel → $39 Initiates Coverage On → Hold
02/25/2020 200.43% Cantor Fitzgerald $48 → $42 Maintains Neutral
02/25/2020 300.57% Sidoti & Co. $70 → $56 Maintains Buy
10/29/2019 243.35% Cantor Fitzgerald $71 → $48 Downgrades Overweight → Neutral
02/26/2019 BTIG Downgrades Buy → Neutral

What is the target price for Orthofix Medical (OFIX)?

The latest price target for Orthofix Medical (NASDAQ: OFIX) was reported by BTIG on September 12, 2023. The analyst firm set a price target for $0.00 expecting OFIX to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Orthofix Medical (OFIX)?

The latest analyst rating for Orthofix Medical (NASDAQ: OFIX) was provided by BTIG, and Orthofix Medical downgraded their neutral rating.

When is the next analyst rating going to be posted or updated for Orthofix Medical (OFIX)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Orthofix Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Orthofix Medical was filed on September 12, 2023 so you should expect the next rating to be made available sometime around September 12, 2024.

Is the Analyst Rating Orthofix Medical (OFIX) correct?

While ratings are subjective and will change, the latest Orthofix Medical (OFIX) rating was a downgraded with a price target of $0.00 to $0.00. The current price Orthofix Medical (OFIX) is trading at is $13.98, which is out of the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment